Impact of cerebellum neuromodulation on social and executive functions in autism
Official title: Cerebellum and Autism: Regional Specialization for Social and Executive Functions
Run by American University · NCT05396352 · Data updated 2026-11-12
This study is testing how a brain stimulation technique affects social skills and thinking abilities in young adults with autism and those without it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | American University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT05396352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are young adults aged 18-35, both neurotypical and those diagnosed with autism spectrum disorder.
✕Probably not a fit
Patients outside the age range of 18-35 or those with cognitive function scores below the required threshold may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore how neuromodulation of the cerebellum affects social and executive functions in both neurotypical young adults and those with autism. Researchers will utilize transcranial direct current stimulation to target specific cerebellar regions, hypothesizing that different areas influence distinct cognitive abilities. Participants will undergo various tasks assessing social learning and cognitive flexibility after receiving either excitatory, inhibitory, or sham stimulation. The study will also incorporate functional neuroimaging to observe changes in brain activity related to these functions.
Why it matters
Potential benefit: If successful, this study could lead to targeted neuromodulation therapies that improve social and cognitive functions in individuals with autism.
How similar studies have gone: While the approach of targeting cerebellar regions is innovative, similar studies have shown promise in neuromodulation techniques for cognitive and social function improvements.
Who can join: the full rules
Show full inclusion / exclusion criteria
Please note: This study takes place at American University and Georgetown University in Washington, DC. We do not have funds for travel and lodging available for this study, so participants should be local to the DC region. Inclusion Criteria: All participants * Aged 18-35 * Able to provide written, informed consent * NIH Toolbox age-adjusted Cognitive Function Composite standard score ≥ 85 * Native English speaker * Right-handed * Not pregnant * Able to attend all study sessions * Pass safety screening for MRI and neuromodulation (e.g. no metal in body, implanted devices, history of seizure, claustrophobia) Additional INCLUSION criteria for adults with autism Either * Prior research-reliable diagnosis of autism spectrum disorder (ASD) Or * Meet DSM-5 criteria for ASD confirmed with ADOS-2 via research-reliable clinical assessment Exclusion Criteria: Neurotypical adults * Age \<18 or \>35 * NIH Toolbox age-adjusted Cognitive Function Composite standard score \< 85 * Contraindications for MRI or neuromodulation with tDCS (e.g. metal in body, pacemaker or other implanted device, history of seizure, claustrophobia) * Current or prior history of neurological or neurodevelopmental condition or brain injury * Psychotropic medication * Pregnancy Adults with autism * Age \<18 or \>35 * Participants with a legal authorized representative * NIH Toolbox age-adjusted Cognitive Function Composite standard score \< 85 * Contraindications for MRI or neuromodulation with tDCS (e.g. metal in body, pacemaker or other implanted device, history of seizure, claustrophobia) * Pregnancy
Where it's running
-
American University
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Principal investigator: Kathleen Gunthert, Ph.D. — American University
- Study coordinator: Catherine Stoodley, D.Phil.
- Email: stoodley@american.edu
- Phone: 202-476-4799
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AdiaVita and glutathione for autism in kids and teens
This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.
-
Online test of BlinkLab Dx1 for autism in kids aged 2–11
This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.
-
Trauma‑Focused Cognitive Behavioral Therapy adapted for autistic children and teens (pilot implementation)
This pilot will try TF‑CBT adapted for autistic children and teens with trauma-related symptoms to see if community mental health clinicians can deliver it and families find it acceptable.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
-
Static balance testing in children with autism using a virtual reality system
This project tests whether a virtual reality rehabilitation system can measure static balance differences in children with autism aged 6–10.
-
Do AdiaVita stem cells plus glutathione help kids with autism more than glutathione alone?
This 12-month study tests whether adding AdiaVita stem cells and exosomes to glutathione helps children aged 3–12 with autism more than glutathione alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.